The tumour-targeting human L19-IL2 immunocytokine

Preclinical safety studies, phase I clinical trial in patients with solid tumours and expansion into patients with advanced renal cell carcinoma
Thumbnail
Metadata only
Author
Johannsen, Manfred
Spitaleri, Gianluca
Curigliano, Giuseppe
Roigas, Jan
Weikert, Steffen
Kempkensteffen, Carsten
Roemer, Andreas
Kloeters, Christian
Rogalla, Patrik
Pecher, Gabriele
Miller, Kurt
Berndt, Alexander
Kosmehl, Hartwig
Trachsel, Eveline
Kaspar, Manuela
Lovato, Valeria
Gonzalez-Iglesias, Reinerio
Giovannoni, Leonardo
Menssen, Hans D.
Neri, Dariocc
Braud, Filippo de
Show all
Date
2010-11
Type
  • Journal Article
Publication status
published
External links
Search via SFX
Journal / series
European Journal of Cancer
Volume
46(16)
Pages / Article No.
2926 - 2935
Publisher
Elsevier
Subject
Immunotherapy; Phase I/II study; Renal cell carcinoma; Solid tumours
Organisational unit
03463 - Neri, Dario / Neri, Dario  
Notes
Received 26 May 2010, Revised 19 July 2010, Accepted 22 July 2010, Available online 24 August 2010.
More
Show all metadata
Citations
Cited 76 times in Web of Science
Cited 91 times in Scopus
ETH Bibliography
yes
Altmetrics